Author

H. F. Staats

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

B. T. Johnson-Weaver· 1 shared C. C. LaBranchi· 1 shared C. Zeng· 1 shared D. C. Montifiori· 1 shared D. I. Jones· 1 shared D. J. Pickup· 1 shared D. W. Pascual· 1 shared F. Huang· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

B. T. Johnson-Weaver

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Lung-selective Cas13d-based nanotherapy inhibits lethal SARS-CoV-2 infection by targeting host protease Ctsl

Z. Cui, C. Zeng, F. Huang, F. Yuan, J. Yan, Y. Zhao, J. Huang, H. F. Staats, J. I. Everitt, G. D. Sempowski, H. Wang, Y. Dong, S.-L. Liu, Q. Wang

This paper develops a lung-selective Cas13d-based nanotherapy targeting Ctsl to inhibit SARS-CoV-2 infection, showing improved survival and reduced viral burden in mice.

bioRxiv · Oct 3, 2021 · PreprintMicrobiology

Optimized Mucosal MVA Prime/ Soluble gp120 Boost Vaccination Regimen Induces Similar Antibody Responses as an Intramuscular Regimen

D. I. Jones, J. J. Pollara, B. T. Johnson-Weaver, C. C. LaBranchi, D. C. Montifiori, D. J. Pickup, S. R. Permar, S. N. Abraham, M. Maddaloni, D. W. Pascual, H. F. Staats

This study shows that an optimized mucosal vaccination regimen can induce serum antibody responses similar to intramuscular vaccination, but does not provide better mucosal protection against HIV.

bioRxiv · Mar 11, 2019Immunology